101 related articles for article (PubMed ID: 12165635)
1. FDA issues warning about 'new' tamoxifen risk.
Twombly R
J Natl Cancer Inst; 2002 Aug; 94(15):1122. PubMed ID: 12165635
[No Abstract] [Full Text] [Related]
2. Tamoxifen effects.
Nogales FF; Carvia R
Am J Surg Pathol; 1998 Jul; 22(7):907-8. PubMed ID: 9669356
[No Abstract] [Full Text] [Related]
3. Tamoxifen may increase risk of uterine sarcoma.
Gottlieb S
BMJ; 2002 Jul; 325(7354):7. PubMed ID: 12098716
[No Abstract] [Full Text] [Related]
4. Uterine sarcoma associated with tamoxifen use.
Wysowski DK; Honig SF; Beitz J
N Engl J Med; 2002 Jun; 346(23):1832-3. PubMed ID: 12050351
[No Abstract] [Full Text] [Related]
5. Association of tamoxifen and uterine sarcoma.
Wickerham DL; Fisher B; Wolmark N; Bryant J; Costantino J; Bernstein L; Runowicz CD
J Clin Oncol; 2002 Jun; 20(11):2758-60. PubMed ID: 12039943
[No Abstract] [Full Text] [Related]
6. One step forward or one step back with tamoxifen?
Gelmon K
Lancet; 2000 Sep; 356(9233):868-9. PubMed ID: 11036885
[No Abstract] [Full Text] [Related]
7. [Uterine sarcoma associated with tamoxifen use after breast cancer: Review of the pathogenesis].
Homer L; Muller M; Dupré PF; Lucas B; Pradier O
J Gynecol Obstet Biol Reprod (Paris); 2009 Dec; 38(8):629-33. PubMed ID: 19833452
[TBL] [Abstract][Full Text] [Related]
8. [Uterine pathology in women with breast cancer treated with tamoxifen].
Carcangiu ML
Pathologica; 1997 Jun; 89(3):223-33. PubMed ID: 9380417
[No Abstract] [Full Text] [Related]
9. Tamoxifen-associated endometrial carcinoma in postmenopausal breast cancer patients.
Altaras MM; Aviram R; Beyth Y
Gynecol Oncol; 1991 Jun; 41(3):270. PubMed ID: 1869106
[No Abstract] [Full Text] [Related]
10. Tamoxifen-related uterine malignancies: carcinomas or sarcomas?
Delaloge S; Pautier P; Duvillard P
Int J Gynecol Cancer; 2004; 14(2):395. PubMed ID: 15086746
[No Abstract] [Full Text] [Related]
11. Anti-estrogens come of age: a pioneer looks back.
Nelson NJ
J Natl Cancer Inst; 1998 May; 90(9):646-7. PubMed ID: 9586657
[No Abstract] [Full Text] [Related]
12. The risk of developing uterine sarcoma after tamoxifen use.
Lavie O; Barnett-Griness O; Narod SA; Rennert G
Int J Gynecol Cancer; 2008; 18(2):352-6. PubMed ID: 18334013
[TBL] [Abstract][Full Text] [Related]
13. [Uterine sarcomas... or uterine carcinosarcomas?].
Leung F; Terzibachian JJ
J Gynecol Obstet Biol Reprod (Paris); 2010 Apr; 39(2):172. PubMed ID: 20079975
[No Abstract] [Full Text] [Related]
14. Tamoxifen and breast cancer prevention: are we aware of the risks?
Mandeville R; Houde M
Cancer Prev Control; 1997; 1(1):66-72. PubMed ID: 9765729
[No Abstract] [Full Text] [Related]
15. [Tamoxifen and endometrial pathology].
Negoiţă M; Terinte C; Mihailovici MS
Rev Med Chir Soc Med Nat Iasi; 2010; 114(4):1114-7. PubMed ID: 21500468
[TBL] [Abstract][Full Text] [Related]
16. [Expansive uterine myoma during tamoxifen therapy. 11 cases].
Le Bouëdec G; de Latour M; Dauplat J
Presse Med; 1995 Nov; 24(36):1694-6. PubMed ID: 8545398
[TBL] [Abstract][Full Text] [Related]
17. Uterine stromal sarcoma following tamoxifen treatment.
Beer TW; Buchanan R; Buckley CH
J Clin Pathol; 1995 Jun; 48(6):596. PubMed ID: 7665715
[No Abstract] [Full Text] [Related]
18. Case of uterine papillary serous carcinoma following tamoxifen treatment that could not be diagnosed during screening.
Maenaka T; Egawa-Takata T; Hisamoto K; Kunishige I; Nishio Y; Tsujimoto M
J Obstet Gynaecol Res; 2014 May; 40(5):1450-4. PubMed ID: 24606575
[TBL] [Abstract][Full Text] [Related]
19. Nolvadex: cancer warning added to tamoxifen label.
Nursing; 2002 Oct; 32(10):24. PubMed ID: 12400585
[No Abstract] [Full Text] [Related]
20. FDA, Zeneca Pharmaceuticals warn of increased uterine-cancer risk with tamoxifen treatment.
Am J Hosp Pharm; 1994 Jun; 51(11):1380-1. PubMed ID: 7942869
[No Abstract] [Full Text] [Related]
[Next] [New Search]
